Q0162
Q0162 – Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use a · NDC Crosswalk & Billing Units
HCPCS Level II Q-code · Medicare Part B drug billing
Q-code
● 174 NDCs crosswalked per 1 MG $0.016/unit ASP+6%
📋 Q0162 summary
Q0162 is a HCPCS Level II Q-code used to bill Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete thera..., billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with Q0162: Ondansetron Hcl(Q0162)*, Ondansetron, Ondansetron Hydrochloride
Code Q0162
Billing unit 1 MG Payment limit $0.016/unit NDC-Crosswalk 174
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeQ0162
DescriptorOndansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Billing unit1 MG
Payment limit / unit$0.016
Est. ASP / unit$0.015 est.
Mapped NDCs174
Data periodQ3 2026
Last updated2026-08-20
💊 About Ondansetron DRUG GUIDE
Ondansetron is used to prevent nausea and vomiting in several situations.
Oral forms (tablets, orally disintegrating tablets, and oral solution) are approved to prevent nausea and vomiting from highly or moderately emetogenic (nausea-causing) cancer chemotherapy, from radiation therapy to the abdomen or whole body, and from surgery.Ondansetron injection (given intravenously or intramuscularly in a clinical setting) is approved to prevent nausea and vomiting from emetogenic cancer chemotherapy — including high-dose cisplatin — in adults and children as young as 6 months old, as well as to prevent postoperative nausea and vomiting.
Clinical overview from our editorial drug guide for Ondansetron. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.016
Est. ASP / unit
$0.015 est.
Est. after 2% sequester
$0.016
HCPCS dosage
1 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionOndansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment group—
Action codeN — No maintenance this year
Effective date2012-01-01
Date added2012-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of Q0162 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under Q0162 LEAST EXPENSIVE FIRST
174 NDCs map to Q0162. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.016/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00904-6551-61 | ondansetron 4 mg/1 TABLET, FILM COATED | Major | 100 BLISTER PACK in 1 CARTON (0904-6551-61... | 4 mg/1 | 400 | $6.40 | $0.060 | ● Active | CMS ASP |
| 16714-0159-01 | Ondansetron 4 mg/1 TABLET, FILM COATED | NorthStar | 30 TABLET, FILM COATED in 1 BOTTLE (16714-... | 4 mg/1 | 120 | $1.92 | $0.060 | ● Active | CMS + PDAC |
| 50268-0621-15 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | AvPAK | 50 BLISTER PACK in 1 BOX (50268-621-15) /... | 4 mg/1 | 200 | $3.20 | $0.060 | ● Active | CMS ASP |
| 55111-0153-30 | ONDANSETRON 4 mg/1 TABLET, FILM COATED | Dr. | 30 TABLET, FILM COATED in 1 BOTTLE (55111-... | 4 mg/1 | 120 | $1.92 | $0.060 | ● Active | CMS + PDAC |
| 62135-0350-30 | ONDANSETRON 4 mg/1 TABLET | Chartwell | 30 TABLET in 1 BOTTLE (62135-350-30) | 4 mg/1 | 120 | $1.92 | $0.060 | ● Active | CMS + PDAC |
| 68084-0220-01 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | American | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (6808... | 4 mg/1 | 400 | $6.40 | $0.060 | ● Active | CMS ASP |
| 68462-0105-30 | Ondansetron 4 mg/1 TABLET, FILM COATED | Glenmark | 30 TABLET, FILM COATED in 1 BOTTLE (68462-... | 4 mg/1 | 120 | $1.92 | $0.060 | ● Active | CMS + PDAC |
| 69339-0171-01 | Ondansetron 4 mg/1 TABLET | Natco | 100 TABLET in 1 BOTTLE (69339-171-01) | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 69339-0171-05 | Ondansetron 4 mg/1 TABLET | Natco | 500 TABLET in 1 BOTTLE (69339-171-05) | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 57237-0075-50 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Rising | 500 TABLET, FILM COATED in 1 BOTTLE (57237... | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 69339-0171-03 | Ondansetron 4 mg/1 TABLET | Natco | 30 TABLET in 1 BOTTLE (69339-171-03) | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 62135-0350-05 | ONDANSETRON 4 mg/1 TABLET | Chartwell | 500 TABLET in 1 BOTTLE (62135-350-05) | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 57237-0075-30 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Rising | 30 TABLET, FILM COATED in 1 BOTTLE (57237-... | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 65862-0187-30 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Aurobindo | 30 TABLET, FILM COATED in 1 BOTTLE (65862-... | 4 mg/1 | 4 | $0.06 | $0.060 | ● Active | PDAC |
| 62756-0130-01 | ondansetron hydrochloride 4 mg/1 TABLET, FILM COATED | Sun | 30 TABLET, FILM COATED in 1 BOTTLE (62756-... | 4 mg/1 | 4 | $0.06 | $0.065 | ● Active | PDAC |
| 63304-0458-30 | ONDANSETRON 4 mg/1 TABLET, FILM COATED | Sun | 30 TABLET, FILM COATED in 1 BOTTLE (63304-... | 4 mg/1 | 4 | $0.06 | $0.066 | ● Active | PDAC |
| 00904-6552-61 | ondansetron 8 mg/1 TABLET, FILM COATED | Major | 100 BLISTER PACK in 1 CARTON (0904-6552-61... | 8 mg/1 | 800 | $12.80 | $0.081 | ● Active | CMS ASP |
| 16714-0160-01 | Ondansetron 8 mg/1 TABLET, FILM COATED | NorthStar | 30 TABLET, FILM COATED in 1 BOTTLE (16714-... | 8 mg/1 | 240 | $3.84 | $0.081 | ● Active | CMS + PDAC |
| 50268-0622-15 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | AvPAK | 50 BLISTER PACK in 1 BOX (50268-622-15) /... | 8 mg/1 | 400 | $6.40 | $0.081 | ● Active | CMS ASP |
| 55111-0154-30 | ONDANSETRON 8 mg/1 TABLET, FILM COATED | Dr. | 30 TABLET, FILM COATED in 1 BOTTLE (55111-... | 8 mg/1 | 240 | $3.84 | $0.081 | ● Active | CMS + PDAC |
| 62135-0351-05 | ONDANSETRON 8 mg/1 TABLET | Chartwell | 500 TABLET in 1 BOTTLE (62135-351-05) | 8 mg/1 | 4,000 | $64.00 | $0.081 | ● Active | CMS + PDAC |
| 62135-0351-30 | ONDANSETRON 8 mg/1 TABLET | Chartwell | 30 TABLET in 1 BOTTLE (62135-351-30) | 8 mg/1 | 240 | $3.84 | $0.081 | ● Active | CMS + PDAC |
| 68084-0221-01 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | American | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (6808... | 8 mg/1 | 800 | $12.80 | $0.081 | ● Active | CMS ASP |
| 68462-0106-30 | Ondansetron 8 mg/1 TABLET, FILM COATED | Glenmark | 30 TABLET, FILM COATED in 1 BOTTLE (68462-... | 8 mg/1 | 240 | $3.84 | $0.081 | ● Active | CMS + PDAC |
| 69339-0172-01 | Ondansetron 8 mg/1 TABLET | Natco | 100 TABLET in 1 BOTTLE (69339-172-01) | 8 mg/1 | 8 | $0.13 | $0.081 | ● Active | PDAC |
| 57237-0076-50 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Rising | 500 TABLET, FILM COATED in 1 BOTTLE (57237... | 8 mg/1 | 8 | $0.13 | $0.081 | ● Active | PDAC |
| 69339-0172-03 | Ondansetron 8 mg/1 TABLET | Natco | 30 TABLET in 1 BOTTLE (69339-172-03) | 8 mg/1 | 8 | $0.13 | $0.081 | ● Active | PDAC |
| 57237-0076-30 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Rising | 30 TABLET, FILM COATED in 1 BOTTLE (57237-... | 8 mg/1 | 8 | $0.13 | $0.081 | ● Active | PDAC |
| 65862-0188-30 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Aurobindo | 30 TABLET, FILM COATED in 1 BOTTLE (65862-... | 8 mg/1 | 8 | $0.13 | $0.081 | ● Active | PDAC |
| 62756-0131-01 | ondansetron hydrochloride 8 mg/1 TABLET, FILM COATED | Sun | 30 TABLET, FILM COATED in 1 BOTTLE (62756-... | 8 mg/1 | 8 | $0.13 | $0.092 | ● Active | PDAC |
| 63304-0459-30 | ONDANSETRON 8 mg/1 TABLET, FILM COATED | Sun | 30 TABLET, FILM COATED in 1 BOTTLE (63304-... | 8 mg/1 | 8 | $0.13 | $0.099 | ● Active | PDAC |
| 16714-0200-30 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | NorthStar | 3 BLISTER PACK in 1 CARTON (16714-200-30)... | 4 mg/1 | 120 | $1.92 | $0.121 | ● Active | CMS + PDAC |
| 62135-0121-30 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Chartwell | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 120 | $1.92 | $0.121 | ● Active | CMS + PDAC |
| 68001-0246-04 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | BluePoint | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 120 | $1.92 | $0.121 | ● Active | CMS + PDAC |
| 68001-0246-17 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | BluePoint | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 4 mg/1 | 120 | $1.92 | $0.121 | ● Active | CMS ASP |
| 68462-0157-13 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Glenmark | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 4 mg/1 | 120 | $1.92 | $0.121 | ● Active | CMS + PDAC |
| 83980-0012-13 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Ipca | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 4 | $0.06 | $0.121 | ● Active | PDAC |
| 57237-0077-50 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Rising | 500 TABLET, ORALLY DISINTEGRATING in 1 BOT... | 4 mg/1 | 4 | $0.06 | $0.121 | ● Active | PDAC |
| 57237-0077-30 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Rising | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 4 | $0.06 | $0.121 | ● Active | PDAC |
| 65862-0390-10 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Aurobindo | 3 BLISTER PACK in 1 CARTON (65862-390-10)... | 4 mg/1 | 4 | $0.06 | $0.121 | ● Active | PDAC |
| 62756-0240-64 | ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Sun | 3 BLISTER PACK in 1 DOSE PACK (62756-240-6... | 4 mg/1 | 4 | $0.06 | $0.121 | Obsolete | PDAC |
| 16714-0201-10 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | NorthStar | 1 BLISTER PACK in 1 CARTON (16714-201-10)... | 8 mg/1 | 80 | $1.28 | $0.162 | ● Active | CMS + PDAC |
| 16714-0201-30 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | NorthStar | 3 BLISTER PACK in 1 CARTON (16714-201-30)... | 8 mg/1 | 240 | $3.84 | $0.162 | ● Active | CMS + PDAC |
| 62135-0122-30 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Chartwell | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 240 | $3.84 | $0.162 | ● Active | CMS + PDAC |
| 68001-0247-04 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | BluePoint | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 240 | $3.84 | $0.162 | ● Active | CMS + PDAC |
| 68001-0247-17 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | BluePoint | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 8 mg/1 | 240 | $3.84 | $0.162 | ● Active | CMS ASP |
| 68462-0158-11 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Glenmark | 10 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 8 mg/1 | 80 | $1.28 | $0.162 | ● Active | CMS + PDAC |
| 68462-0158-13 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Glenmark | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 8 mg/1 | 240 | $3.84 | $0.162 | ● Active | CMS + PDAC |
| 83980-0013-13 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Ipca | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 8 | $0.13 | $0.162 | ● Active | PDAC |
| 57237-0078-50 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Rising | 500 TABLET, ORALLY DISINTEGRATING in 1 BOT... | 8 mg/1 | 8 | $0.13 | $0.162 | ● Active | PDAC |
| 57237-0078-30 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Rising | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 8 | $0.13 | $0.162 | ● Active | PDAC |
| 68001-0247-16 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | BluePoint | 10 TABLET, ORALLY DISINTEGRATING in 1 BLIS... | 8 mg/1 | 8 | $0.13 | $0.162 | ● Active | PDAC |
| 65862-0391-10 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Aurobindo | 3 BLISTER PACK in 1 CARTON (65862-391-10)... | 8 mg/1 | 8 | $0.13 | $0.162 | ● Active | PDAC |
| 62756-0356-66 | ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Sun | 1 BLISTER PACK in 1 DOSE PACK (62756-356-6... | 8 mg/1 | 8 | $0.13 | $0.168 | Obsolete | PDAC |
| 62756-0356-64 | ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Sun | 3 BLISTER PACK in 1 DOSE PACK (62756-356-6... | 8 mg/1 | 8 | $0.13 | $0.168 | Obsolete | PDAC |
| 16714-0671-02 | Ondansetron 4 mg/5mL SOLUTION | NorthStar | 1 BOTTLE, PLASTIC in 1 CARTON (16714-671-0... | 4 mg/5mL | 40 | $0.64 | $0.280 | ● Active | CMS ASP |
| 62135-0555-58 | Ondansetron Hydrochloride 4 mg/5mL SOLUTION | Chartwell | 50 mL in 1 BOTTLE (62135-555-58) | 4 mg/5mL | 40 | $0.64 | $0.280 | ● Active | CMS + PDAC |
| 00121-0882-51 | Ondansetron 4 mg/5mL SOLUTION | PAI | 50 mL in 1 BOTTLE, PLASTIC (0121-0882-51) | 4 mg/5mL | 0.8 | $0.01 | $0.280 | ● Active | PDAC |
| 51672-4091-03 | Ondansetron 4 mg/5mL SOLUTION | Taro | 1 BOTTLE in 1 CARTON (51672-4091-3) / 50... | 4 mg/5mL | 0.8 | $0.01 | $0.290 | Obsolete | PDAC |
| 43063-0792-06 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | PD-Rx | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC... | 8 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 43063-0857-02 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 2 TABLET, ORALLY DISINTEGRATING in 1 BOTTL... | 4 mg/1 | 8 | $0.13 | — | ● Active | CMS ASP |
| 43063-0857-04 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTL... | 4 mg/1 | 16 | $0.26 | — | ● Active | CMS ASP |
| 43063-0857-05 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTL... | 4 mg/1 | 20 | $0.32 | — | ● Active | CMS ASP |
| 43063-0857-06 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTL... | 4 mg/1 | 24 | $0.38 | — | ● Active | CMS ASP |
| 43063-0857-10 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 43063-0857-20 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 20 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 43063-0870-04 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTL... | 8 mg/1 | 32 | $0.51 | — | ● Active | CMS ASP |
| 43063-0870-10 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | PD-Rx | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-1128-01 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1128-1)... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 50090-1200-00 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1200-0)... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-1200-01 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1200-1)... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-1200-02 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1200-2)... | 4 mg/1 | 20 | $0.32 | — | ● Active | CMS ASP |
| 50090-1200-03 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 3 BLISTER PACK in 1 CARTON (50090-1200-3)... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 50090-1201-00 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1201-0)... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-1658-00 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 PACKET (50090-1658-0)... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-1658-01 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 PACKET (50090-1658-1)... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-1658-02 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 PACKAGE (50090-1658-2)... | 4 mg/1 | 20 | $0.32 | — | ● Active | CMS ASP |
| 50090-1658-03 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX,... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 50090-1659-00 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-1659-0)... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-1660-00 | Ondansetron ODT | A-S | — | — | 32 | $0.51 | — | — | CMS ASP |
| 50090-1660-01 | Ondansetron ODT | A-S | — | — | 240 | $3.84 | — | — | CMS ASP |
| 50090-1660-02 | Ondansetron ODT | A-S | — | — | 80 | $1.28 | — | — | CMS ASP |
| 50090-1660-03 | Ondansetron ODT | A-S | — | — | 160 | $2.56 | — | — | CMS ASP |
| 50090-2343-00 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 10 BLISTER PACK in 1 CARTON (50090-2343-0)... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-2343-01 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 20 BLISTER PACK in 1 CARTON (50090-2343-1)... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-2343-02 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 5 BLISTER PACK in 1 CARTON (50090-2343-2)... | 4 mg/1 | 20 | $0.32 | — | ● Active | CMS ASP |
| 50090-2343-03 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 30 BLISTER PACK in 1 CARTON (50090-2343-3)... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 50090-3178-00 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 10 TABLET, FILM COATED in 1 BOTTLE (50090-... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-3178-01 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC... | 4 mg/1 | 24 | $0.38 | — | ● Active | CMS ASP |
| 50090-3178-02 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTI... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-3178-04 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC... | 4 mg/1 | 12 | $0.19 | — | ● Active | CMS ASP |
| 50090-3178-05 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 12 TABLET, FILM COATED in 1 BOTTLE, PLASTI... | 4 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 50090-3185-00 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 4 TABLET, FILM COATED in 1 BOTTLE (50090-3... | 8 mg/1 | 32 | $0.51 | — | ● Active | CMS ASP |
| 50090-3185-01 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTI... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-3185-02 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC... | 8 mg/1 | 24 | $0.38 | — | ● Active | CMS ASP |
| 50090-3185-03 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTI... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 50090-3185-04 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC... | 8 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 50090-3769-00 | Ondansetron | A-S | — | — | 32 | $0.51 | — | — | CMS ASP |
| 50090-3769-01 | Ondansetron | A-S | — | — | 80 | $1.28 | — | — | CMS ASP |
| 50090-3769-03 | Ondansetron | A-S | — | — | 240 | $3.84 | — | — | CMS ASP |
| 50090-3769-04 | Ondansetron | A-S | — | — | 48 | $0.77 | — | — | CMS ASP |
| 50090-4632-00 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 4 TABLET, ORALLY DISINTEGRATING in 1 BLIST... | 8 mg/1 | 32 | $0.51 | — | ● Active | CMS ASP |
| 50090-4632-01 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 3 BLISTER PACK in 1 CARTON (50090-4632-1)... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 50090-4632-02 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 1 BLISTER PACK in 1 CARTON (50090-4632-2)... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-4632-03 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | A-S | 2 BLISTER PACK in 1 CARTON (50090-4632-3)... | 8 mg/1 | 160 | $2.56 | — | ● Active | CMS ASP |
| 50090-4671-00 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 4 TABLET, FILM COATED in 1 BOTTLE (50090-4... | 8 mg/1 | 32 | $0.51 | — | ● Active | CMS ASP |
| 50090-4671-01 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 10 TABLET, FILM COATED in 1 BOTTLE (50090-... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-4671-02 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 3 TABLET, FILM COATED in 1 BOTTLE (50090-4... | 8 mg/1 | 24 | $0.38 | — | ● Active | CMS ASP |
| 50090-4671-03 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 30 TABLET, FILM COATED in 1 BOTTLE (50090-... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 50090-4671-04 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | A-S | 6 TABLET, FILM COATED in 1 BOTTLE (50090-4... | 8 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 50090-5346-01 | Ondansetron ODT | A-S | — | — | 240 | $3.84 | — | — | CMS ASP |
| 50090-5346-02 | Ondansetron ODT | A-S | — | — | 80 | $1.28 | — | — | CMS ASP |
| 50090-5346-03 | Ondansetron ODT | A-S | — | — | 160 | $2.56 | — | — | CMS ASP |
| 50090-6342-00 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 10 TABLET, FILM COATED in 1 BOTTLE (50090-... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 50090-6342-01 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 6 TABLET, FILM COATED in 1 BOTTLE (50090-6... | 4 mg/1 | 24 | $0.38 | — | ● Active | CMS ASP |
| 50090-6342-02 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 20 TABLET, FILM COATED in 1 BOTTLE (50090-... | 4 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 50090-6342-05 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | A-S | 12 TABLET, FILM COATED in 1 BOTTLE (50090-... | 4 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 50268-0647-14 | Ondansetron 4 mg/5mL SOLUTION | AvPAK | 40 CUP, UNIT-DOSE in 1 TRAY (50268-647-14)... | 4 mg/5mL | 160 | $2.56 | — | ● Active | CMS + PDAC |
| 60687-0252-86 | Ondansetron 4 mg/5mL SOLUTION | American | 3 TRAY in 1 CASE (60687-252-86) / 10 CUP,... | 4 mg/5mL | 120 | $1.92 | — | ● Active | CMS + PDAC |
| 62135-0555-24 | Ondansetron Hydrochloride 4 mg/5mL SOLUTION | Chartwell | 2 TRAY in 1 BOX (62135-555-24) / 10 PACKA... | 4 mg/5mL | 80 | $1.28 | — | ● Active | CMS + PDAC |
| 68788-7565-01 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Preferred | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 68788-7565-03 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | Preferred | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 68788-7644-01 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Preferred | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 68788-7644-03 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Preferred | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 68788-8365-05 | Ondansetron | Preferred | — | — | 40 | $0.64 | — | — | CMS ASP |
| 68788-8582-01 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Preferred | 10 TABLET, FILM COATED in 1 BOTTLE (68788-... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 68788-8582-02 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Preferred | 12 TABLET, FILM COATED in 1 BOTTLE (68788-... | 8 mg/1 | 96 | $1.54 | — | ● Active | CMS ASP |
| 68788-8582-03 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Preferred | 30 TABLET, FILM COATED in 1 BOTTLE (68788-... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 68788-8651-01 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 10 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 68788-8651-02 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 12 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 68788-8651-03 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 30 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 68788-8651-05 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 15 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 60 | $0.96 | — | ● Active | CMS ASP |
| 68788-8666-01 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | Preferred | 30 TABLET, ORALLY DISINTEGRATING in 1 PACK... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 68788-9368-01 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 10 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 40 | $0.64 | — | ● Active | CMS ASP |
| 68788-9368-02 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 12 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 48 | $0.77 | — | ● Active | CMS ASP |
| 68788-9368-03 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | Preferred | 30 TABLET, FILM COATED in 1 BOTTLE (68788-... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 68788-9402-01 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Preferred | 10 TABLET, FILM COATED in 1 BOTTLE (68788-... | 8 mg/1 | 80 | $1.28 | — | ● Active | CMS ASP |
| 68788-9402-03 | Ondansetron Hydrochloride 8 mg/1 TABLET, FILM COATED | Preferred | 30 TABLET, FILM COATED in 1 BOTTLE (68788-... | 8 mg/1 | 240 | $3.84 | — | ● Active | CMS ASP |
| 72336-0073-30 | Ondansetron 16 mg/1 TABLET, ORALLY DISINTEGRATING | Lifsa | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 16 mg/1 | 480 | $7.68 | — | ● Active | CMS ASP |
| 72789-0034-12 | Ondansetron Hydrochloride 4 mg/1 TABLET, FILM COATED | PD-Rx | 12 TABLET, FILM COATED in 1 BOTTLE, PLASTI... | 4 mg/1 | 120 | $1.92 | — | ● Active | CMS ASP |
| 68999-0555-24 | Ondansetron Hydrochloride 4 mg/5mL SOLUTION | Chartwell | 2 TRAY in 1 BOX (68999-555-24) / 10 CUP,... | 4 mg/5mL | 0.8 | $0.01 | — | ● Active | PDAC |
| 42291-0458-30 | Ondansetron 8 mg/1 TABLET, ORALLY DISINTEGRATING | AvKARE | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 8 mg/1 | 8 | $0.13 | — | ● Active | PDAC |
| 42291-0457-30 | Ondansetron 4 mg/1 TABLET, ORALLY DISINTEGRATING | AvKARE | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTT... | 4 mg/1 | 4 | $0.06 | — | ● Active | PDAC |
| 51407-0004-30 | Ondansetron 8 mg/1 TABLET | Golden | 30 TABLET in 1 BOTTLE (51407-004-30) | 8 mg/1 | 8 | $0.13 | — | ● Active | PDAC |
| 51407-0003-30 | Ondansetron 4 mg/1 TABLET | Golden | 30 TABLET in 1 BOTTLE (51407-003-30) | 4 mg/1 | 4 | $0.06 | — | ● Active | PDAC |
| 51407-0004-05 | Ondansetron 8 mg/1 TABLET | Golden | 500 TABLET in 1 BOTTLE (51407-004-05) | 8 mg/1 | 8 | $0.13 | — | ● Active | PDAC |
| 51407-0003-05 | Ondansetron 4 mg/1 TABLET | Golden | 500 TABLET in 1 BOTTLE (51407-003-05) | 4 mg/1 | 4 | $0.06 | — | ● Active | PDAC |
| 45802-0127-14 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 45802-0127-65 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 45802-0205-14 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 45802-0205-65 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 55111-0156-11 | ONDANSETRON 24 mg/1 TABLET, FILM COATED | Dr. | 1 DOSE PACK in 1 BOX (55111-156-11) / 1 T... | 24 mg/1 | 24 | $0.38 | — | ● Active | PDAC |
| 55111-0154-13 | ONDANSETRON 8 mg/1 TABLET, FILM COATED | Dr. | 3 DOSE PACK in 1 BOX (55111-154-13) / 1 T... | 8 mg/1 | 8 | $0.13 | — | ● Active | PDAC |
| 00904-7073-93 | ONDANSETRON 4 MG/5 ML | Unknown | — | — | 0.8 | $0.01 | — | — | PDAC |
| 71930-0018-52 | ONDANSETRON (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 71930-0017-52 | ONDANSETRON HCL (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 50436-1880-01 | ONDANSETRON HYDROCHLORIDE 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 71930-0018-30 | ONDANSETRON (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 71930-0017-30 | ONDANSETRON HCL (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 00078-0675-15 | ZOFRAN 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 00078-0676-15 | ZOFRAN (FILM COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 51079-0524-20 | ONDANSETRON HYDROCHLORIDE (USP,10X10,FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 51079-0524-01 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 00781-1681-31 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 00378-7734-97 | ONDANSETRON (USP) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 00378-7734-93 | ONDANSETRON (USP) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 00378-7732-93 | ONDANSETRON (USP) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 00378-0344-93 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 00378-0315-93 | ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 33358-0370-02 | ZOFRAN 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 00173-0447-00 | ZOFRAN 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 33358-0369-02 | ZOFRAN 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
| 45963-0539-30 | ONDANSETRON (USP,FILM-COATED) 8 MG | Unknown | — | — | 8 | $0.13 | — | — | PDAC |
| 00781-5238-64 | ONDANSETRON (USP,3X10,STRAWBERRY) 4 MG | Unknown | — | — | 4 | $0.06 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$34.36
Claims
127
Beneficiaries
50
Spend / beneficiary
$0.69
Spend / claim
$0.27
Trend by period
Where Q0162 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #820 of 824
#814
CEFAZOLIN SODIUM(J06... J0688
$69.34
#815
HEPARIN SODIUM J1643
$64.49
#816
DIMENHYDRINATE J1240
$52.85
#817
BREVIBLOC* J1805
$44.41
#818
DOXERCALCIFEROL* J1270
$40.18
#819
ACETAMINOPHEN(J0134) J0134
$34.54
#820
ONDANSETRON HCL(Q016... Q0162
$34.36
#821
HYDROXOCOBALAMIN J3425
$20.01
#822
ACETADOTE* J0132
$8.67
#823
DAPTOMYCIN-0.9% NACL J0874
$1.38
#824
CHLOROPROCAINE HCL* J2401
$1.04
Total claims — #605 of 824
#600
METRO IV* J1836
132
#601
VIBATIV J3095
131
#602
ARTACENT WOUND, PER... Q4169
131
#603
LEVOTHYROXINE SODIUM... J0651
128
#604
TEVIMBRA J9329
128
#605
ONDANSETRON HCL(Q016... Q0162
127
#606
AMNIO QUAD-CORE, PER... Q4294
126
#607
EPYSQLI Q5151
124
#608
CEFTAROLINE FOSAMIL* J0712
122
#609
ELOCTATE J7205
122
#610
AZITHROMYCIN* J0456
121
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $34.36 | 50 | 127 | $0.69 | $0.27 |
| 2025 (Q1-Q4) | $1.2K | 216 | 600 | $5.59 | $2.01 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$75.01
Medicare paid
$60.07
Submitted services
40,412
Denial rate
86.0%
Allowed / service
$0.01
Submitted charges
$71.4K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where Q0162 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
📊 What bills under Q0162
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
174 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ Q0162 billing FAQ
What is HCPCS code Q0162?
Q0162 is a HCPCS Level II Q-code used to bill Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for Q0162?
One unit of Q0162 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.
How many units of Q0162 should I bill?
Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for Q0162?
The Medicare Part B payment limit is $0.016 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.016 per unit. Payment limits are revised quarterly.
Which NDCs bill under Q0162?
174 NDCs currently map to Q0162 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean Q0162 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.